ArticleJCO precision oncology2020

Combined CDK4/6 and PD-1 Inhibition in Refractory SMARCA4-Deficient Small-Cell Carcinoma of the Ovary, Hypercalcemic Type.

Elizabeth K Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.